US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 2.680
  • +0.180+7.20%
Close May 9 16:00 ET
  • 2.680
  • 0.0000.00%
Post 18:29 ET
683.24MMarket Cap-2977P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
-45.55%-37.1M
-30.59%-44.33M
Net income from continuing operations
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
-43.74%-70.25M
41.97%-36.32M
Operating gains losses
---1.52M
186.08%1.51M
114.98%437K
-41.32%642K
----
----
-251.38%-1.75M
-789.60%-2.92M
330.71%1.09M
-96.80%14K
Depreciation and amortization
-0.06%5.02M
12.38%20.25M
0.32%5.06M
10.45%5.1M
21.36%5.06M
20.06%5.03M
32.27%18.02M
10.43%5.04M
12.96%4.62M
38.57%4.17M
Other non cash items
129.74%595K
30.38%-4.65M
--0
-262.35%-3.23M
-81.50%582K
50.77%-2M
-244.53%-6.68M
52.14%-7.76M
775.25%1.99M
-68.90%3.15M
Change In working capital
24.91%-3.24M
104.17%3.42M
103.97%1.72M
38.71%2.43M
109.44%3.58M
-80.45%-4.31M
-2,142.71%-82.02M
-1,299.36%-43.39M
-69.52%1.75M
-6,622.48%-37.98M
-Change in prepaid assets
245.83%595K
258.79%3.13M
342.90%3.15M
2.50%-664K
158.37%1.05M
-2.77%-408K
71.83%-1.97M
-636.36%-1.3M
63.56%-681K
108.83%406K
-Change in payables and accrued expense
1.90%-3.72M
265.20%745K
-127.11%-1.31M
137.89%3.2M
204.54%2.65M
-9.69%-3.79M
-95.60%204K
12.30%4.85M
41.98%1.35M
-173.85%-2.53M
-Change in other current liabilities
-0.89%-113K
-110.20%-449K
-107.94%-112K
-110.34%-112K
0.00%-113K
-105.54%-112K
-73.92%4.4M
-38.40%1.41M
-88.35%1.08M
-103.50%-113K
-Change in other working capital
----
----
----
----
----
----
-705.61%-84.65M
-1,620.17%-48.35M
100.04%1K
-1,264.20%-35.74M
Cash from discontinued investing activities
Operating cash flow
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
-45.55%-37.1M
-30.59%-44.33M
Investing cash flow
Cash flow from continuing investing activities
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
60.61%-57.09M
163.38%25.02M
Net PPE purchase and sale
98.04%-30K
88.94%-2.69M
99.45%-25K
93.01%-195K
86.99%-933K
84.25%-1.53M
62.94%-24.28M
55.38%-4.58M
76.02%-2.79M
70.62%-7.17M
Net investment purchase and sale
-34.62%22.02M
1,366.19%186.73M
-296.50%-100.67M
82.53%-41.95M
142.65%295.66M
-57.79%33.69M
122.71%12.74M
108.49%51.23M
-269.08%-240.15M
-39.34%121.85M
Cash from discontinued investing activities
Investing cash flow
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
60.61%-57.09M
163.38%25.02M
Financing cash flow
Cash flow from continuing financing activities
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
996.42%4.76M
-99.38%2.46M
Net common stock issuance
----
--0
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
--103K
-80.17%2.2M
-7.84%882K
-98.60%72K
-49.29%1.25M
--0
17.52%11.1M
-87.07%957K
869.19%5.13M
290.00%2.46M
Net other financing activities
-10.14%-76K
0.87%-457K
-30.85%-123K
---215K
---50K
---69K
---461K
---94K
----
----
Cash from discontinued financing activities
Financing cash flow
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
996.42%4.76M
-99.38%2.46M
Net cash flow
Beginning cash position
17.84%145.93M
-57.92%123.83M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
108.91%294.29M
-70.41%116.59M
-63.53%206.02M
-8.97%222.88M
Current changes in cash
-41.54%-20M
112.96%22.1M
-2,040.45%-140.57M
169.15%61.84M
781.89%114.95M
80.22%-14.13M
-211.11%-170.46M
107.27%7.24M
47.68%-89.43M
-105.27%-16.86M
End cash Position
14.79%125.94M
17.84%145.93M
17.84%145.93M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
-57.92%123.83M
-70.41%116.59M
-63.53%206.02M
Free cash flow
11.94%-42.05M
14.16%-166.38M
9.34%-40.66M
5.05%-37.88M
22.15%-40.09M
17.09%-47.75M
-1.08%-193.83M
-3.15%-44.85M
-7.56%-39.89M
11.80%-51.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 9.08%-42.02M3.46%-163.69M-0.91%-40.64M-1.57%-37.69M11.67%-39.16M3.43%-46.21M-34.30%-169.56M-21.24%-40.27M-45.55%-37.1M-30.59%-44.33M
Net income from continuing operations 9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M-43.74%-70.25M41.97%-36.32M
Operating gains losses ---1.52M186.08%1.51M114.98%437K-41.32%642K---------251.38%-1.75M-789.60%-2.92M330.71%1.09M-96.80%14K
Depreciation and amortization -0.06%5.02M12.38%20.25M0.32%5.06M10.45%5.1M21.36%5.06M20.06%5.03M32.27%18.02M10.43%5.04M12.96%4.62M38.57%4.17M
Other non cash items 129.74%595K30.38%-4.65M--0-262.35%-3.23M-81.50%582K50.77%-2M-244.53%-6.68M52.14%-7.76M775.25%1.99M-68.90%3.15M
Change In working capital 24.91%-3.24M104.17%3.42M103.97%1.72M38.71%2.43M109.44%3.58M-80.45%-4.31M-2,142.71%-82.02M-1,299.36%-43.39M-69.52%1.75M-6,622.48%-37.98M
-Change in prepaid assets 245.83%595K258.79%3.13M342.90%3.15M2.50%-664K158.37%1.05M-2.77%-408K71.83%-1.97M-636.36%-1.3M63.56%-681K108.83%406K
-Change in payables and accrued expense 1.90%-3.72M265.20%745K-127.11%-1.31M137.89%3.2M204.54%2.65M-9.69%-3.79M-95.60%204K12.30%4.85M41.98%1.35M-173.85%-2.53M
-Change in other current liabilities -0.89%-113K-110.20%-449K-107.94%-112K-110.34%-112K0.00%-113K-105.54%-112K-73.92%4.4M-38.40%1.41M-88.35%1.08M-103.50%-113K
-Change in other working capital -------------------------705.61%-84.65M-1,620.17%-48.35M100.04%1K-1,264.20%-35.74M
Cash from discontinued investing activities
Operating cash flow 9.08%-42.02M3.46%-163.69M-0.91%-40.64M-1.57%-37.69M11.67%-39.16M3.43%-46.21M-34.30%-169.56M-21.24%-40.27M-45.55%-37.1M-30.59%-44.33M
Investing cash flow
Cash flow from continuing investing activities -31.60%21.99M1,694.87%184.05M-315.85%-100.69M274.60%99.67M511.18%152.91M223.09%32.15M90.51%-11.54M163.16%46.65M60.61%-57.09M163.38%25.02M
Net PPE purchase and sale 98.04%-30K88.94%-2.69M99.45%-25K93.01%-195K86.99%-933K84.25%-1.53M62.94%-24.28M55.38%-4.58M76.02%-2.79M70.62%-7.17M
Net investment purchase and sale -34.62%22.02M1,366.19%186.73M-296.50%-100.67M82.53%-41.95M142.65%295.66M-57.79%33.69M122.71%12.74M108.49%51.23M-269.08%-240.15M-39.34%121.85M
Cash from discontinued investing activities
Investing cash flow -31.60%21.99M1,694.87%184.05M-315.85%-100.69M274.60%99.67M511.18%152.91M223.09%32.15M90.51%-11.54M163.16%46.65M60.61%-57.09M163.38%25.02M
Financing cash flow
Cash flow from continuing financing activities 139.13%27K-83.61%1.74M-12.05%759K-103.00%-143K-51.32%1.2M-102.70%-69K-97.35%10.64M-88.34%863K996.42%4.76M-99.38%2.46M
Net common stock issuance ------0------------------0------------
Proceeds from stock option exercised by employees --103K-80.17%2.2M-7.84%882K-98.60%72K-49.29%1.25M--017.52%11.1M-87.07%957K869.19%5.13M290.00%2.46M
Net other financing activities -10.14%-76K0.87%-457K-30.85%-123K---215K---50K---69K---461K---94K--------
Cash from discontinued financing activities
Financing cash flow 139.13%27K-83.61%1.74M-12.05%759K-103.00%-143K-51.32%1.2M-102.70%-69K-97.35%10.64M-88.34%863K996.42%4.76M-99.38%2.46M
Net cash flow
Beginning cash position 17.84%145.93M-57.92%123.83M145.73%286.5M9.05%224.65M-50.78%109.71M-57.92%123.83M108.91%294.29M-70.41%116.59M-63.53%206.02M-8.97%222.88M
Current changes in cash -41.54%-20M112.96%22.1M-2,040.45%-140.57M169.15%61.84M781.89%114.95M80.22%-14.13M-211.11%-170.46M107.27%7.24M47.68%-89.43M-105.27%-16.86M
End cash Position 14.79%125.94M17.84%145.93M17.84%145.93M145.73%286.5M9.05%224.65M-50.78%109.71M-57.92%123.83M-57.92%123.83M-70.41%116.59M-63.53%206.02M
Free cash flow 11.94%-42.05M14.16%-166.38M9.34%-40.66M5.05%-37.88M22.15%-40.09M17.09%-47.75M-1.08%-193.83M-3.15%-44.85M-7.56%-39.89M11.80%-51.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg